These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33794947)

  • 1. Correction to: New approaches to symptomatic treatments for Alzheimer's disease.
    Cummings J
    Mol Neurodegener; 2021 Apr; 16(1):21. PubMed ID: 33794947
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease-modifying trials in Alzheimer's disease: a European task force consensus.
    Vellas B; Andrieu S; Sampaio C; Wilcock G;
    Lancet Neurol; 2007 Jan; 6(1):56-62. PubMed ID: 17166802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease.
    Venigalla M; Gyengesi E; Münch G
    Neural Regen Res; 2015 Aug; 10(8):1181-5. PubMed ID: 26487830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: from molecular pathogenesis to innovative therapies.
    Scarpini E; Cogiamanian F
    Expert Rev Neurother; 2003 Sep; 3(5):619-30. PubMed ID: 19810962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.
    Aisen P; Touchon J; Andrieu S; Boada M; Doody R; Nosheny RL; Langbaum JB; Schneider L; Hendrix S; Wilcock G; Molinuevo JL; Ritchie C; Ousset PJ; Cummings J; Sperling R; DeKosky ST; Lovestone S; Hampel H; Petersen R; Legrand V; Egan M; Randolph C; Salloway S; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2016; 3(2):68-74. PubMed ID: 29210442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
    Meiner Z; Rosenmann H
    Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating stem cell trials for Alzheimer's disease.
    Hunsberger JG; Rao M; Kurtzberg J; Bulte JWM; Atala A; LaFerla FM; Greely HT; Sawa A; Gandy S; Schneider LS; Doraiswamy PM
    Lancet Neurol; 2016 Feb; 15(2):219-230. PubMed ID: 26704439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting Circulating MicroRNAs as Biomarkers in Alzheimer's Disease.
    Kenny A; Jimenez-Mateos EM; Calero M; Medina M; Engel T
    Methods Mol Biol; 2018; 1779():471-484. PubMed ID: 29886551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.
    Stahl SM
    CNS Spectr; 2018 Oct; 23(5):291-297. PubMed ID: 30382934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect and mechanism of acupuncture on Alzheimer's disease.
    Zeng BY; Salvage S; Jenner P
    Int Rev Neurobiol; 2013; 111():181-95. PubMed ID: 24215923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mémantine (Ebixa): a new therapeutic strategy for the treatment of moderate to severe forms of Alzheimer's disease].
    Gallarda T; Lôo H
    Encephale; 2004; 30(1):69-79. PubMed ID: 15029079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs for Alzheimer's disease and other dementias.
    Bullock R
    Br J Psychiatry; 2002 Feb; 180():135-9. PubMed ID: 11823323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of medicinal plants on Alzheimer's disease and memory deficits.
    Akram M; Nawaz A
    Neural Regen Res; 2017 Apr; 12(4):660-670. PubMed ID: 28553349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease].
    Petit AE; Mangeard H; Chazard E; Puisieux F
    Encephale; 2017 Feb; 43(1):21-26. PubMed ID: 27039155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
    Cummings JL; Miller BL; Christensen DD; Cherry D
    CNS Spectr; 2008 Feb; 13(2 Suppl 2):1-20; quiz 22. PubMed ID: 18264030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: early diagnosis and treatment.
    Chu LW
    Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.